History of the Institute for Neuroimmunology and Multiple Sclerosis Research (IMSF)
The Institute for Neuroimmunology and Multiple Sclerosis Research (IMSF) was founded in January 2004 with the help of the Hertie Foundation. With support from Lower Saxony’s state government, the University of Göttingen’s Medical Faculty reconstructed the second floor of the neuroscientific research complex in Waldweg 33 and established the Department of Experimental and Clinical Neuroimmunology. Prof. Ralf Gold was appointed director of the department and chairman of the IMSF.
In August 2006, Prof. Gold changed to St. Joseph’s Hospital in Bochum. After an interim period under the supervision of Prof. Wolfgang Brück (Head of Research & Teaching, Executive Board Director of the University Medical Center Göttingen), in 2008 Prof. Alexander Flügel was appointed as chairman of the IMSF and director of the Department of Experimental and Clinical Neuroimmunology (Curriculum Vitae). In 2018 the department was renamed to the Institute for Neuroimmunology and Multiple Sclerosis Research.
The research at the IMSF is focused on analyzing the pathomechanisms of multiple sclerosis. The aim of our research activities is to promote the development of novel therapeutic approaches for the treatment of multiple sclerosis and to understand the mechanisms of action of established treatments.